Renaissance Technologies LLC Reduces Stock Position in FONAR Co. (NASDAQ:FONR)

Renaissance Technologies LLC lowered its stake in shares of FONAR Co. (NASDAQ:FONR – Get Rating) by 9.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 345,616 shares of the medical equipment provider’s stock after selling 37,100 shares during the period. Renaissance Technologies LLC owned 5.27% of FONAR worth $4,890,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Money Concepts Capital Corp raised its position in shares of FONAR by 67.1% in the third quarter. Money Concepts Capital Corp now owns 144,587 shares of the medical equipment provider’s stock worth $2,046,000 after buying an additional 58,064 shares in the last quarter. State Street Corp raised its position in shares of FONAR by 9.6% in the first quarter. State Street Corp now owns 19,354 shares of the medical equipment provider’s stock worth $359,000 after buying an additional 1,696 shares in the last quarter. UBS Group AG raised its position in shares of FONAR by 53,600.0% in the first quarter. UBS Group AG now owns 2,148 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 2,144 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of FONAR by 3.2% in the first quarter. Dimensional Fund Advisors LP now owns 376,486 shares of the medical equipment provider’s stock worth $6,984,000 after buying an additional 11,745 shares in the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of FONAR by 99.1% in the first quarter. Acadian Asset Management LLC now owns 14,018 shares of the medical equipment provider’s stock worth $258,000 after buying an additional 6,978 shares in the last quarter. Hedge funds and other institutional investors own 44.93% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. StockNews.com upgraded FONAR from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, February 21st. TheStreet downgraded FONAR from a “b-” rating to a “c+” rating in a research report on Tuesday, December 20th.

FONAR Stock Performance

NASDAQ FONR opened at $16.20 on Friday. The stock’s 50-day simple moving average is $17.73 and its two-hundred day simple moving average is $16.63. FONAR Co. has a twelve month low of $13.28 and a twelve month high of $19.32. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.59 and a current ratio of 8.78.

FONAR Company Profile

(Get Rating)

FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. It operates through the Manufacturing and Servicing of Medical Equipment and Management of Diagnostic Imaging Center segments. The Manufacturing and Servicing of Medical Equipment segment promotes its product, Fonar Upright MRI.